Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Microviable Therapeutics Logo
Microviable Therapeutics Growth Score
33
CB Rank
142320
Heat Score
64
Microviable Therapeutics develops microbiota ecosystem products and microbiome therapies to improve human health.
Founded
obfuscation
PrivateSeed Gijón, Asturias, Spain1-10 www.microviable.com
Health Care
Life Science
Overview

Microviable Therapeutics
Total Funding
obfuscation
Growth Score
33
Heat Score
64

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score33
-1 pts
in past quarter
Heat Score 64
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Microviable Therapeutics

CB Rank
142320
Microviable Therapeutics develops microbiota ecosystem products and microbiome therapies to improve human health.
Founded
obfuscation
PrivateSeed Gijón, Asturias, Spain1-10 www.microviable.com
Health Care
Life Science

Funding Rounds

Seed
OBF
in
obfuscation

Details

Legal Name Microviable Therapeutics SL
Also Known As Microviable Tx
Operating Status Active
Company Type For Profit
About the Company
Microviable Therapeutics is working to improve human health by creating an entire microbiota ecosystem and microbiome therapeutics. They develop novel biological drugs and personalized therapies. It is a preclinical stage exploring innovative biological therapeutics for infectious disorders based on commensal microorganisms.
Contact Email info@microviable.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

GutAlive
An anaerobic microbiome collection kit that preserves the viability and original composition of microbiota samples during collection and transport.
MVT-201
An oral biological drug candidate based on intestinal microbiota for treating infectious diseases, currently in preclinical development.

Research & Development

Microviable Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed
obfuscation
Seed Round - Microviable Therapeutics Logo
Seed Round - Microviable Therapeutics
1
obfuscation
Immunomet Intolerance and DysbiosisSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Feb 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 20, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 6, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 25, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

298
1.36%
 in past month

IT Spend

$250.4KThis year, Microviable Therapeutics is projected to spend $250.4K on IT, according to Aberdeen.

Active Website Tech Count

30Microviable Therapeutics is actively using 30 technologies for its website, according to BuiltWith. These include HSTS, Google Tag Manager, and  LetsEncrypt.

Total IP

1Microviable Therapeutics has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Microviable Therapeutics's headquarters? Microviable Therapeutics is located in Gijón, Asturias, Spain.Who invested in Microviable Therapeutics? Microviable Therapeutics is funded by Immunomet Intolerance and Dysbiosis.When was the last funding round for Microviable Therapeutics? Microviable Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Microviable Therapeutics's competitors? Alternatives and possible competitors to Microviable Therapeutics may include Ferring, MaaT Pharma, and  ENTEROME.How much funding has Microviable Therapeutics raised to date? Microviable Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|